Assignee
APPLIED MOLECULAR EVOLUTION
US·16 granted patents·6 pending applications·342 citations·filing 1995–2010
Top patents by PatentIndex Score
22 records- 0198US7723484B2Anti-EGFR antibodiesAPPLIED MOLECULAR EVOLUTION·Filed 2006·Granted May 25, 2010·70 cites·4 claims
- 0298US7560112B2Anti-il-6 antibodies, compositions, methods and usesAPPLIED MOLECULAR EVOLUTION·Filed 2006·Granted Jul 14, 2009·84 cites·16 claims
- 0395US7740847B2Variant Fc regionsAPPLIED MOLECULAR EVOLUTION·Filed 2005·Granted Jun 22, 2010·68 cites·13 claims
- 0489US7175996B1Methods of optimizing antibody variable region binding affinityAPPLIED MOLECULAR EVOLUTION·Filed 2000·Granted Feb 13, 2007·14 cites·6 claims
- 0587US7575747B2Aβ binding moleculesAPPLIED MOLECULAR EVOLUTION·Filed 2004·Granted Aug 18, 2009·10 cites·5 claims
- 0687US7422744B2Methods of treating cancer with alphavbeta3-specific antibodiesAPPLIED MOLECULAR EVOLUTION·Filed 2003·Granted Sep 9, 2008·12 cites·34 claims
- 0786US7049121B2Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of useAPPLIED MOLECULAR EVOLUTION·Filed 2002·Granted May 23, 2006·20 cites·10 claims
- 0882US7371382B2Methods of inhibiting αvβ3-mediated binding with αvβ3-specific antibodiesAPPLIED MOLECULAR EVOLUTION·Filed 2002·Granted May 13, 2008·11 cites·56 claims
- 0980US7101978B2TNF-α binding moleculesAPPLIED MOLECULAR EVOLUTION·Filed 2003·Granted Sep 5, 2006·9 cites·5 claims
- 1076US7541033B2Humanized anti-IL-1β antibodiesAPPLIED MOLECULAR EVOLUTION·Filed 2004·Granted Jun 2, 2009·7 cites·7 claims
- 1175US7070973B2Butyrylcholinesterase variants and methods of useAPPLIED MOLECULAR EVOLUTION·Filed 2000·Granted Jul 4, 2006·4 cites·2 claims
- 1270US7435799B2TNF-α binding moleculesAPPLIED MOLECULAR EVOLUTION·Filed 2004·Granted Oct 14, 2008·1 cites·2 claims
- 1365US7667007B2αvβ3-specific antibodiesAPPLIED MOLECULAR EVOLUTION·Filed 2008·Granted Feb 23, 2010·0 cites·5 claims
- 1465US7422745B2Methods of treating cancer with vαβ3-specific antibodiesAPPLIED MOLECULAR EVOLUTION·Filed 2003·Granted Sep 9, 2008·0 cites·95 claims
- 1564US6893845B1Surface expression libraries of heteromeric receptorsAPPLIED MOLECULAR EVOLUTION·Filed 1995·Granted May 17, 2005·15 cites·34 claims
- 1662US2005069554A1Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of useAPPLIED MOLECULAR EVOLUTION·Filed 2004·Application pending·0 cites
- 1761US2005003469A1Tumor specific human monoclonal antibodies and methods of useAPPLIED MOLECULAR EVOLUTION·Filed 2004·Application pending·0 cites
- 1861US2005003384A1Surface expression libraries of heteromeric receptorsAPPLIED MOLECULAR EVOLUTION·Filed 2004·Application pending·0 cites
- 1960US6787638B1Tumor specific human monoclonal antibodies and methods of useAPPLIED MOLECULAR EVOLUTION·Filed 1998·Granted Sep 7, 2004·17 cites·7 claims
- 2053US2008213281A1Butyrylcholinesterase Variants that Alter the Activity of Chemotherapeutic AgentsAPPLIED MOLECULAR EVOLUTION·Filed 2003·Application pending·0 cites
- 2148US2004161802A1Methods for producing and improving therapeutic potency of binding polypeptidesAPPLIED MOLECULAR EVOLUTION·Filed 2004·Application pending·0 cites
- 2247US2010166755A1Anti-egfr antibodiesAPPLIED MOLECULAR EVOLUTION·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when APPLIED MOLECULAR EVOLUTION files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →